Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells

Oncotarget
Stephen L AbramsJ A McCubrey

Abstract

A critical problem in leukemia as well as other cancer therapies is the development of chemotherapeutic drug-resistance. We have developed models of hematopoietic drug resistance that are based on expression of dominant-negative TP53 [TP53 (DN)] or constitutively-active MEK1 [MEK1(CA)] oncogenes in the presence of chemotherapeutic drugs. In human cancer, functional TP53 activity is often lost in human cancers. Also, activation of the Raf/MEK/ERK pathway frequently occurs due to mutations/amplification of upstream components of this and other interacting pathways. FL5.12 is an interleukin-3 (IL-3) dependent hematopoietic cell line that is sensitive to doxorubicin (a.k.a Adriamycin). FL/Doxo is a derivative cell line that was isolated by culturing the parental FL5.12 cells in doxorubicin for prolonged periods of time. FL/Doxo + TP53 (DN) and FL/Doxo + MEK1 (CA) are FL/Doxo derivate cell lines that were infected with retrovirus encoding TP53 (DN) or MEK1 (CA) and are more resistant to doxorubicin than FL/Doxo cells. This panel of cell lines displayed differences in the sensitivity to inhibitors that suppress mTORC1, BCL2/BCLXL, MEK1 or MDM2 activities, as well as, the proteasomal inhibitor MG132. The expression of key genes involv...Continue Reading

References

Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J P McKearnB Fagg
Jul 30, 2002·The EMBO Journal·Maria CastedoGuido Kroemer
Mar 27, 2007·Advances in Enzyme Regulation·James A McCubreyAlberto M Martelli
Nov 10, 2009·Advances in Enzyme Regulation·James A McCubreyLinda S Steelman
Nov 3, 2010·Advances in Enzyme Regulation·James A McCubreyLinda S Steelman
Dec 25, 2010·Journal of Proteome Research·Qing-Rong ChenJaved Khan
Jul 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Lei HuangZhi-Min Yuan
Jul 7, 2011·Oncotarget·Melissa L SokoloskyJames A McCubrey
Mar 9, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Maria Rosaria RicciardiMichele Milella
Apr 4, 2012·Oncotarget·Melchiorre CervelloGiuseppe Montalto
Jul 18, 2012·Cell Cycle·Melchiorre CervelloGiuseppe Montalto

❮ Previous
Next ❯

Datasets Mentioned

BETA
ABT-737

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.